Skip to main content
Top

2021 | OriginalPaper | Hoofdstuk

3. Gynaecologische tumoren

Auteur : Drs. M. A. D. Haverkort

Gepubliceerd in: Radiotherapie bij de oncologische patiënt

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Inhoud – 1 Inleiding – 2 Cervixcarcinoom – 3 Tumoren van het corpus uteri – 4 Tumoren van het ovarium – 5 Tumoren van de tuba – 6 Tumoren van de vulva – 7 Tumoren van de vagina. – Bij radiotherapie van gynaecologische tumoren moet onderscheid gemaakt worden tussen de diverse organen. Endometriumcarcinoom komt het meest voor. De primaire behandeling is meestal operatie. Postoperatieve radiotherapie wordt afhankelijk van de risicofactoren gegeven en kan bestaan uit in- of uitwendige radiotherapie of een combinatie daarvan, soms samen met chemotherapie. Ook voor vulvacarcinoom is operatie de eerste keuze en wordt alleen bij risicofactoren postoperatief bestraald. Bij inoperabiliteit wordt primaire chemoradiatie gegeven. Cervixcarcinoom (afhankelijk van het stadium) en vaginacarcinoom worden behandeld met primaire (chemo)radiatie, waarbij brachytherapie een onmisbaar deel van de behandeling is. Postoperatieve (chemo)radiotherapie bij cervixcarcinoom wordt afhankelijk van de risicofactoren gegeven. Bij ovarium- en tubacarcinoom heeft radiotherapie alleen een rol in de palliatieve setting. Moderne radiotherapie bestaat uit meer conformele technieken: intensity modulated radiotherapy (IMRT) en volumetric modulated arc therapy (VMAT), en eventueel planadaptatie, met dagelijks online positieverificatie en 3D image-based brachytherapie.
Literatuur
3.
go back to reference Gospodarowicz M, Wittekind C, Brierley J. Cervix uteri. TNM classification of malignant tumours (8th ed., pp. 166–74). Oxford UK: John Wiley And Sons Ltd; 2016. Gospodarowicz M, Wittekind C, Brierley J. Cervix uteri. TNM classification of malignant tumours (8th ed., pp. 166–74). Oxford UK: John Wiley And Sons Ltd; 2016.
4.
go back to reference Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecolog Cancer. 2018;28:641–55.CrossRef Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecolog Cancer. 2018;28:641–55.CrossRef
6.
go back to reference Schmid M, Franckena M, Kirchheiner K, Sturdza A, Georg P, Dörr W, Pötter R. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecol Oncol. 2014;133(2):256–62.CrossRef Schmid M, Franckena M, Kirchheiner K, Sturdza A, Georg P, Dörr W, Pötter R. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecol Oncol. 2014;133(2):256–62.CrossRef
7.
go back to reference Lutgens L, Koper P, Jobsen J, Van der Steen-Banasik E, Creutzberg C, Van den Berg H, et al. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: results of the randomized RADHOC trial. Radiother Oncol. 2016;120(3):378–82.CrossRef Lutgens L, Koper P, Jobsen J, Van der Steen-Banasik E, Creutzberg C, Van den Berg H, et al. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: results of the randomized RADHOC trial. Radiother Oncol. 2016;120(3):378–82.CrossRef
8.
go back to reference Udayashankar AH, Noorjahan S, Srikantia N, Babu KR, Muzumder S. Immobilization versus no immobilization for pelvic external beam radiotherapy. Rep Pract Oncol Radiother [Internet]. 2018;23(4):233–41.CrossRef Udayashankar AH, Noorjahan S, Srikantia N, Babu KR, Muzumder S. Immobilization versus no immobilization for pelvic external beam radiotherapy. Rep Pract Oncol Radiother [Internet]. 2018;23(4):233–41.CrossRef
9.
go back to reference Jensen NBK, Assenholt MS, Fokdal LU, Vestergaard A, Schouboe A, Kjaersgaard EB, et al. Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer. Phys Imaging Radiat Oncol [Internet]. 2018;2019(9):14–20. Jensen NBK, Assenholt MS, Fokdal LU, Vestergaard A, Schouboe A, Kjaersgaard EB, et al. Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer. Phys Imaging Radiat Oncol [Internet]. 2018;2019(9):14–20.
10.
go back to reference Boje N, Jensen K, Sanggaard Assenholt M, Fokdal L, Vestergaard A, Schouboe A, et al. Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer. Phys Imag Radiat Oncol. 2019;9:14–20.CrossRef Boje N, Jensen K, Sanggaard Assenholt M, Fokdal L, Vestergaard A, Schouboe A, et al. Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer. Phys Imag Radiat Oncol. 2019;9:14–20.CrossRef
11.
go back to reference Schoot A, De Boer P, Visser J, Stalpers L, Rasch C, Bel A. Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy. Acta Oncologica. 2017;56(5):667–74.CrossRef Schoot A, De Boer P, Visser J, Stalpers L, Rasch C, Bel A. Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy. Acta Oncologica. 2017;56(5):667–74.CrossRef
12.
go back to reference Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabander M, Dimopoulos, et al. Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabander M, Dimopoulos, et al. Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45.
13.
go back to reference Chassagne D, Dutreix A, Almond P, Burgers J, Busch M, Joslin C. Dose and volume specification for reporting intracavitary therapy in gynecology (report 38). J Int Commission Radiat Units Measurements. 1985;os20(1). Chassagne D, Dutreix A, Almond P, Burgers J, Busch M, Joslin C. Dose and volume specification for reporting intracavitary therapy in gynecology (report 38). J Int Commission Radiat Units Measurements. 1985;os20(1).
14.
16.
go back to reference Mazeron R, Fokdal L, Kirchheiner K, Georg P, Jastaniyah N, Segedin B, et al.; EMBRACE collaborative group. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016 Sep;120(3):412–9. Mazeron R, Fokdal L, Kirchheiner K, Georg P, Jastaniyah N, Segedin B, et al.; EMBRACE collaborative group. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016 Sep;120(3):412–9.
17.
go back to reference Fokdal L, Pötter R, Kirchheiner K, Lindegaard J, Jensen N, Kirisits et al. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol. 2018;127(3):423–30. https://doi.org/10.1016/j.radonc.2018.05.002. Fokdal L, Pötter R, Kirchheiner K, Lindegaard J, Jensen N, Kirisits et al. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol. 2018;127(3):423–30. https://​doi.​org/​10.​1016/​j.​radonc.​2018.​05.​002.
18.
go back to reference Kirchheiner K, Nout R, Lindegaard J, Haie-Meder C, Mahantshetty U, Segedin, et al. EMBRACE Collaborative Group. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160–6. https://doi.org/10.1016/j.radonc.2015.12.025. Kirchheiner K, Nout R, Lindegaard J, Haie-Meder C, Mahantshetty U, Segedin, et al. EMBRACE Collaborative Group. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160–6. https://​doi.​org/​10.​1016/​j.​radonc.​2015.​12.​025.
19.
go back to reference Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(e10):459–76.CrossRef Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(e10):459–76.CrossRef
23.
go back to reference Froma A, Mast M, Welleweerd H, redacteuren. Techniek in de radiotherapie. 4de ed. Houten: Bohn Stafleu van Loghum; 2020. Froma A, Mast M, Welleweerd H, redacteuren. Techniek in de radiotherapie. 4de ed. Houten: Bohn Stafleu van Loghum; 2020.
Metagegevens
Titel
Gynaecologische tumoren
Auteur
Drs. M. A. D. Haverkort
Copyright
2021
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/16013_2020_26